FDA/American Gastroenterological Association (AGA) Co-sponsored Public Workshop: Changing Regulatory and Reimbursement Paradigms for Medical Devices in the Treatment of Obesity and Metabolic Diseases, December 19-20, 2013
The Food and Drug Administration (FDA) is announcing the following public workshop entitled "Changing Regulatory and Reimbursement Paradigms for Medical Devices in the Treatment of Obesity and Metabolic Diseases: How to Estimate and Reward True Patient-Centric Value in Innovation”.
The purpose of this workshop is to bring together key stakeholders in the development and delivery of new medical technologies. Through this workshop, stakeholders will be able to better clarify their roles and expectations as it pertains to assessing the risk and benefit of medical device procedures, approval, commercialization and coverage. The workshop also aims to enhance collaboration and awareness, which ultimately supports continued innovation in device development.
This meeting will be held December 19 and 20, 2013, beginning at 8:30 a.m. at the following location:
Grand Hyatt Washington
1000 H Street NW
Washington, DC 20001
If you wish to attend this Workshop please visit:
For questions regarding workshop content please contact Herbert Lerner, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. G114, Silver Spring, MD 20993-0002, 301-796-6511, email: Herbert.Lerner@fda.hhs.gov.